dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Cuervo-Arango, Ignacio |
dc.contributor.author | Pérez-Santamarina, Rafael |
dc.contributor.author | Poveda, José Luís |
dc.contributor.author | Romero, José Antonio |
dc.contributor.author | Santamaría Ortiz, Amparo |
dc.contributor.author | Álvarez Román, María Teresa |
dc.date.accessioned | 2020-09-07T10:22:38Z |
dc.date.available | 2020-09-07T10:22:38Z |
dc.date.issued | 2019-10-08 |
dc.identifier.citation | Álvarez-Román MT, Cuervo-Arango I, Pérez-Santamarina R, Luís Poveda J, Romero JA, Santamaría A, et al. Determining the value contribution of emicizumab (Hemlibra ®) for the prophylaxis of haemophilia A with inhibitors in Spain by multi-criteria decision analysis. Glob Reg Heal Technol Assess. 2019 Oct 8;6(1):1–8. |
dc.identifier.issn | 2284-2403 |
dc.identifier.uri | https://hdl.handle.net/11351/5216 |
dc.description | Hemofília A; Inhibidors; Valors del medicament |
dc.description.sponsorship | This work was supported by Hoffmann-La Roche. |
dc.language.iso | eng |
dc.publisher | SAGE Publications |
dc.relation.ispartofseries | Global Health & Technology Assessment;6(1) |
dc.rights | Attribution-NonCommercial 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ |
dc.source | Scientia |
dc.subject | Hemofília |
dc.subject | Medicaments - Eficàcia |
dc.subject | Equips d'especialistes - Espanya |
dc.subject.mesh | Hemophilia A |
dc.subject.mesh | Efficacy |
dc.subject.mesh | Decision Making, Shared |
dc.subject.mesh | Spain |
dc.title | Determining the value contribution of emicizumab (Hemlibra®) for the prophylaxis of haemophilia A with inhibitors in Spain by multi-criteria decision analysis |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1177/2284240319880534 |
dc.subject.decs | hemofilia A |
dc.subject.decs | eficacia |
dc.subject.decs | toma de decisión |
dc.subject.decs | España |
dc.relation.publishversion | https://journals.aboutscience.eu/index.php/grhta/article/view/452 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.authoraffiliation | [Álvarez-Román MT, Pérez-Santamarina R, Romero JA] Hospital Universitario La Paz, Madrid, Spain. [Cuervo-Arango I] Hoffmann-La Roche Ltd, Madrid, Spain. [Poveda JL] Hospital Universitario La Fe, Valencia, Spain. [Santamaría A] Vall d’Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.wos | 000489225800001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |